Placement Completed
Silence Therapeutics placement
US$201m raised
NASDAQ: SLN
Advisers
Silence Therapeutics
Issuer
Not disclosed
Lead managers
- Legal adviser
- Issuer
- Silence Therapeutics
- Issuer based in
- United Kingdom (unverified)
- Completed
- 17 Aug 2026
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Sensei Biotherapeutics placement Feb 2026 · US$200m · Biotech
- AbCellera Biologics equity raising Aug 2026 · US$200m · Biotech
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
- Processa Pharmaceuticals placement Jul 2026 · US$200m · Biotech
- Apnimed IPO Jul 2026 · US$192m · Biotech
Sources
- 17 Aug 2026 Goodwin Advises the Underwriters on Silence’s $201 Million Public Offering goodwinlaw.com




